Sample size calculations for single‐arm survival studies using transformations of the Kaplan–Meier estimator-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sample size calculations for single‐arm survival studies using transformations of the Kaplan–Meier estimator

Published:2020-12-21 Issue:3 Volume:20 Page:499-511
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Nagashima Kengo¹^ORCID,Noma Hisashi²,Sato Yasunori³,Gosho Masahiko⁴

Affiliation:

1. Research Center for Medical and Health Data Science The Institute of Statistical Mathematics Tokyo Japan

2. Department of Data Science The Institute of Statistical Mathematics Tokyo Japan

3. Department of Preventive Medicine and Public Health Keio University School of Medicine Tokyo Japan

4. Department of Biostatistics, Faculty of Medicine University of Tsukuba Ibaraki Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2090

Reference30 articles.

1. Evaluation of Progression-Free Survival as a Surrogate Endpoint for Survival in Chemotherapy and Targeted Agent Metastatic Colorectal Cancer Trials

2. Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival

3. Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622

4. A Large Sample Study of the Life Table and Product Limit Estimates Under Random Censorship

5. A note on confidence intervals and bands for the survival function based on transformations;Borgan Ø;Scand J Stat,1990

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913);Nature Communications;2024-08-08

2. Single-arm clinical trials: design, ethics, principles;BMJ Supportive & Palliative Care;2024-06-04

3. Utility of Presepsin and Interferon-λ3 for Predicting Disease Severity and Clinical Outcomes in COVID-19 Patients;Diagnostics;2023-07-14

4. Quantification of follow‐up time in oncology clinical trials with a time‐to‐event endpoint: Asking the right questions;Pharmaceutical Statistics;2023-03-27

5. Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients;Diagnostics;2023-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3